BiomX
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BiomX and other ETFs, options, and stocks.About PHGE
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively.
PHGE Key Statistics
Stock Snapshot
The current BiomX(PHGE) stock price is $6.45, with a market capitalization of 10.36M. The stock trades at a price-to-earnings (P/E) ratio of -0.21.
On 2026-02-13, BiomX(PHGE) stock moved within a range of $5.40 to $6.82. With shares now at $6.45, the stock is trading +19.4% above its intraday low and -5.5% below the session's peak.
Trading activity shows a volume of 132.97K, compared to an average daily volume of 163.63K.
Over the past 52 weeks, BiomX(PHGE) stock has traded between a high of $22.06 and a low of $1.50.
Over the past 52 weeks, BiomX(PHGE) stock has traded between a high of $22.06 and a low of $1.50.
PHGE News
BiomX ( (PHGE) ) has provided an update. On December 8, 2025, BiomX Israel discontinued its Phase 2b clinical trial of nebulized phage therapy BX004 in cystic...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.